Affordable Access

PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.

Authors
  • Giuliani, Virginia
  • Miller, Meredith A
  • Liu, Chiu-Yi
  • Hartono, Stella R
  • Class, Caleb A
  • Bristow, Christopher A
  • Suzuki, Erika
  • Sanz, Lionel A
  • Gao, Guang
  • Gay, Jason P
  • Feng, Ningping
  • Rose, Johnathon L
  • Tomihara, Hideo
  • Daniele, Joseph R
  • Peoples, Michael D
  • Bardenhagen, Jennifer P
  • Geck Do, Mary K
  • Chang, Qing E
  • Vangamudi, Bhavatarini
  • Vellano, Christopher
  • And 18 more
Publication Date
Jul 30, 2021
Source
eScholarship - University of California
Keywords
License
Unknown
External links

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that has remained clinically challenging to manage. Here we employ an RNAi-based in vivo functional genomics platform to determine epigenetic vulnerabilities across a panel of patient-derived PDAC models. Through this, we identify protein arginine methyltransferase 1 (PRMT1) as a critical dependency required for PDAC maintenance. Genetic and pharmacological studies validate the role of PRMT1 in maintaining PDAC growth. Mechanistically, using proteomic and transcriptomic analyses, we demonstrate that global inhibition of asymmetric arginine methylation impairs RNA metabolism, which includes RNA splicing, alternative polyadenylation, and transcription termination. This triggers a robust downregulation of multiple pathways involved in the DNA damage response, thereby promoting genomic instability and inhibiting tumor growth. Taken together, our data support PRMT1 as a compelling target in PDAC and informs a mechanism-based translational strategy for future therapeutic development.Statement of significancePDAC is a highly lethal cancer with limited therapeutic options. This study identified and characterized PRMT1-dependent regulation of RNA metabolism and coordination of key cellular processes required for PDAC tumor growth, defining a mechanism-based translational hypothesis for PRMT1 inhibitors.

Report this publication

Statistics

Seen <100 times